The algae alkaloid caulerpin reduces DSS colitis by suppressing NF-κB activation and subsequently inhibiting the colonic production of TNFα, IFNγ, IL-6, IFNγ, and IL-17 [48]. The gene discussed is IL17A; the disease is colitis.